NCT01040637View on ClinicalTrials.gov

A Multiple Dose Study of TD-1211 in Healthy Volunteers and Patients With Opioid-Induced Constipation

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
HealthyOpioid-induced Constipation
Interventions
DRUG

TD-1211

Dose level 1

DRUG

TD-1211

Dose level 2

DRUG

TD-1211

Dose level 3

DRUG

TD-1211

Dose Level 4

DRUG

TD-1211

Ascending doses

DRUG

TD-1211

Ascending doses

DRUG

TD-1211

Ascending doses

DRUG

TD-1211

Ascending doses

DRUG

TD-1211

Ascending doses

DRUG

Placebo

Ascending doses

Trial Locations (3)

78209

Clinical Research Unit, San Antonio

84106

Clinical Research Unit, Salt Lake City

91105

Clinical Research Unit, Pasadena

Sponsors
All Listed Sponsors
lead

Theravance Biopharma

INDUSTRY